Showing results (181-190 of 207) with videos related to
Sort By:
Pageof 21
The Journal of Biological Chemistry|August 15, 2003
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell lineJun Kawagoe, Masahide Ohmichi, Toshifumi Takahashi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.The Journal of Biological Chemistry|March 18, 2004
Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer modelsSeiji Mabuchi, Masahide Ohmichi, Yukihiro Nishio, et al.Journal of Ovarian Research|April 28, 2020
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancerKazuya Maeda, Hiroshi Sasaki, Shoko Ueda, et al.Journal of Medical Case Reports|September 28, 2023
Triple repeated fetal congenital heart disease linked to PLD1 mutation: a case reportYuki Masuda, Yoko Nagayasu, Hikaru Murakami, et al.Journal of Contemporary Brachytherapy|January 13, 2021
High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case reportMio Nakata, Ken Yoshida, Taiju Shimbo, et al.Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.International Journal of Molecular Sciences|December 23, 2022
Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell CarcinomaHiroshi Maruoka, Tomohito Tanaka, Hikaru Murakami, et al.Journal of Clinical Medicine|July 14, 2023
Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial CancerShinichi Terada, Tomohito Tanaka, Hikaru Murakami, et al.International Journal of Molecular Sciences|February 10, 2024
Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft ModelsShoko Ueda, Tomohito Tanaka, Kensuke Hirosuna, et al.Pageof 21